November 29, 2016

Regenerating the Retina

Characterizing the retina’s injury response


By Alex Yuan, MD, PhD


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Regenerative therapies hold the promise of restoring vision by replacing diseased retina with normal retina. In recent years, considerable efforts to reprogram stem cells into retinal cells such as photoreceptors have demonstrated the ability to produce photoreceptors and other retinal cell types from embryonic stem cells and induced pluripotent stem cells. However, complete retinal regeneration and integration of these stem cells into injured or diseased retina has not been possible. At Cole Eye Institute, we are using zebrafish to better characterize the injury response of the retina.

Bridging the current knowledge gap

Current strategies in both human clinical trials and animal preclinical studies involve subretinal delivery of mature cells derived from stem cells grown in the laboratory, or immature retinal cells from fetal retina. Successful transplantation of true stem cells, which differentiate into mature retinal cell types capable of integrating into the retinal circuitry, has not yet been demonstrated.

To address this knowledge gap, our laboratory studies retinal regeneration in zebrafish. Unlike humans, primitive vertebrates such as teleost fish are capable of retinal regeneration in response to injury. The zebrafish retina is capable of rapid and complete regeneration in response to a variety of injuries induced by thermal, chemical or mechanical insults. By understanding the differences between the zebrafish regenerative response and the typical scarring response to injury seen in mice and humans, we hope to unlock the secrets to retinal regeneration.

Novel injury model and results

Using a novel thermal laser injury model, we observed the earliest response to injury in the zebrafish retina. Unlike other methods, damage from thermal lasers is rapid and localized. We identified retinal microglia as one of the earliest responders to retinal injury. These cells rapidly migrate to the site of injury prior to the activation of retinal stem cells.


Proliferating stem cells (red) shown with nuclei (blue) from the different layers of the retina

Following this microglial cell migration, Müller glia, which normally serve as retinal support cells, begin to proliferate and assume a retinal stem cell phenotype. These Müller glia-derived stem cells then migrate away from the inner nuclear layer in a radial pattern. We believe they migrate along scaffolds formed by Müller cells. The cells that migrate to the destroyed photoreceptor layer continue to proliferate and eventually differentiate into new photoreceptors. The regeneration and formation of a new layer of photoreceptors takes about three weeks.

Ongoing research in the Regeneration/Cell Therapy Lab

Future investigations in our lab are focused on developing novel surgical tools to place stem cells intraretinally. Our research suggests intraretinal placement could enhance the integration of newly differentiated cells into the remaining retinal architecture. Unlike subretinal injections, intraretinal injections would place these cells adjacent to the Müller cell scaffold, possibly enhancing their ability to migrate to the site of injury.

We hope that our ongoing studies using zebrafish will one day make regenerative therapy in humans a reality.


Dr. Yuan is Principal Investigator of the Regeneration/Cell Therapy Lab at Cole Eye Institute.

Related Articles

September 19, 2023
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

August 14, 2023
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3391159 CQD-Treating Retinoschisis-hero
December 23, 2022
Long-Term Topical Dorzolamide Improves Visual Acuity in Juvenile X-Linked Retinoschisis

Study followed patients an average of eight years

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
September 7, 2022
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
August 23, 2022
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-3049477 New findings in retinal regeneration-Perkins-650×450-4
August 3, 2022
Restoring the Retina: How to Regenerate Photoreceptors in Inherited Retinal Dystrophy

Notch pathway inhibition preserves retinal neurons and promotes regrowth in zebrafish

22-EYE-2952199 CQD-Fixation eye movement abnormalities in amblyopia-Ghasia-650×450
July 29, 2022
Amblyopia: Eye Movement Recordings Enhance Understanding of Visual Deficits

Patients frequently have problems with depth perception and interocular suppression

A Cleveland Clinic Cole Eye Institute ophthalmologist uses intraoperative OCT during retinal surgery.
June 24, 2022
3D Viewing System Improves Surgical-Field-Based Visualization of iOCT Data

Surgeons also report benefits of integrated heads-up display